LYRA THERAPEUTICS INC
LYRA
LYRA was delisted on the 16th of March, 2026.
37 hedge funds and large institutions have $96M invested in LYRA THERAPEUTICS INC in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 7 closing their positions.
14% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 7
3% more funds holding
Funds holding: 36 → 37 (+1)
0.01% less ownership
Funds ownership: 1.21% → 1.2% (-0.01%)
12% less capital invested
Capital invested by funds: $109M → $96M (-$12.9M)
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$680K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$220K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$156K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$127K |
| 5 |
Bank of New York Mellon
New York
|
+$115K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$732K |
| 2 |
Millennium Management
New York
|
-$413K |
| 3 |
PVI
Pura Vida Investments
New York
|
-$390K |
| 4 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$344K |
| 5 |
Two Sigma Investments
New York
|
-$76K |
LYRA Hedge Fund Activity: Q3 2022 in Review
37 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in LYRA THERAPEUTICS INC (LYRA) for Q3 2022, worth a combined $96M — down 12% from $109M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new LYRA positions and 7 closed out — a net gain of 1 holder — while 7 added to existing stakes and 8 trimmed.
The largest buyer was Vanguard Group, adding an estimated $680K. The largest seller was Nantahala Capital Management, cutting an estimated $732K.
- 37 institutional investors held LYRA THERAPEUTICS INC (LYRA) as of Q3 2022, up from 36 in Q2 2022.
- Funds reported $96M of LYRA THERAPEUTICS INC stock for Q3 2022, down 12% quarter-over-quarter.
- 8 funds opened new LYRA THERAPEUTICS INC positions in Q3 2022 and 7 closed out, a net change of +1 holder.
- The largest LYRA THERAPEUTICS INC buyer in Q3 2022 was Vanguard Group, an estimated $680K added.
- The largest LYRA THERAPEUTICS INC seller in Q3 2022 was Nantahala Capital Management, an estimated $732K sold.
Based on aggregated 13F filings for Q3 2022.